Using external trigeminal nerve stimulation to treat migraines in pregnant women
Official title: CEFALY Pregnancy Registry
Run by Cefaly Technology · NCT06788977 · Data updated 2026-11-12
This study is trying to see if a device that stimulates a nerve in the face can safely help pregnant women with migraines feel better.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 44 Years |
| Sex | Women only |
| Enrollment | 550 (estimated) |
| Sponsor | Cefaly Technology Industry-sponsored |
| Locations | 1 site (Darien, Connecticut) |
| Status | Recruiting |
| Started | November 25, 2024 |
| Main results expected | April 2027 |
| Study ends | December 2030 |
| Registry record updated | April 15, 2026 |
| Trial ID | NCT06788977 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pregnant women aged 18 to 44 who have a history of migraines or headaches.
✕Probably not a fit
Patients who are not pregnant or those who do not have a history of migraines or headaches may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This online registry aims to evaluate the safety and effectiveness of external trigeminal nerve stimulation for treating migraines in pregnant women. Participants can be in any trimester of pregnancy and do not need to use the stimulation device to join. The registry will collect data through up to six online surveys over a period of 12 months, focusing on women who have experienced migraines before or during pregnancy. The goal is to gather insights that could inform future treatment options for this population.
Why it matters
Potential benefit: If successful, this could provide a safe and effective treatment option for managing migraines in pregnant women.
How similar studies have gone: While the approach of using external trigeminal nerve stimulation is being explored, this specific application in pregnant women is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients willing and able to provide simple consent for registry participation. 2. Has access to email, text messages via smartphone or computer with internet access 3. Be between the ages of 18 to 44 years at enrollment. 4. Pregnant with one fetus/baby at time of enrollment (singleton pregnancy) 5. Have headaches or migraines prior to pregnancy and continued to have headaches or migraines into pregnancy OR headaches or migraines began while pregnant in the first trimester. 6. Able to provide proof of active intrauterine pregnancy and estimated due date, via online document upload, using any of the following documents: 1. ultrasound report of current pregnancy 2. beta hcg lab report 3. a signed provider's medical documentation confirming intrauterine pregnancy with fetal heart sounds and estimated due date 4. a signed provider's note on a prescription sheet or physician letterhead confirming intrauterine pregnancy and estimated due date Exclusion Criteria: 1. Patients under the age of 18 or over the age of 44 at enrollment 2. Not pregnant at time of enrollment 3. Pregnant with more than one fetus/baby at time of enrollment (multigestational pregnancy) 4. Patients with any other condition which might preclude participation in the opinion of the patient's physician(s) or the study's principal investigator 5. No access to email, smartphone, or computer with internet access
Where it's running
-
https://public.smart-trial.co/#/public/649d77f0e8f8d0fb993d0c61/6626f6a04f0a3c7dd0860e14/662726d84f0a3c7dd08aeaa0/signup?lang=en-us&enforceLanguage=true
Darien, Connecticut, United States Recruiting
Study contacts
- Principal investigator: Deena Kuruvilla, MD
- Study coordinator: Michael A.L. Johnson, MD
- Email: Clinicaltrial@cefaly.com
- Phone: 203-309-3776
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
MOVIN: a virtual program to support mental health during pregnancy and the early months after birth.
This project will test a virtual collaborative-care program called MOVIN to see if it reduces depression and anxiety in pregnant and postpartum people with infants up to 6 months old who have elevated symptoms.
-
Improving postpartum-to-primary care transitions for people with chronic conditions
This study tests whether embedding default PCP appointments, tailored reminder messages, and care recommendations into routine inpatient postpartum care helps people with chronic conditions connect with primary care after delivery.
-
Comparing high-intensity and moderate-intensity exercise during pregnancy and its effects on health and birth outcomes
This study tests whether high-intensity or moderate-intensity exercise during pregnancy can improve health and birth outcomes for moms and their babies.
-
Bonding Before Birth: A mobile program to support first-time expectant couples
A mobile app trial in Singapore tests short weekly exercises for first-time expectant couples to see if it helps reduce depression and improve emotional regulation during pregnancy.
-
Personalized brain stimulation for long-term symptoms after concussion
This study will try personalized, noninvasive brain stimulation (TMS) to reduce dizziness, headaches, memory problems, and other lasting symptoms in adults aged 18–65 after a concussion.
-
Smartphone-supported single-session psychotherapy for postpartum depression
A single online therapy session plus four weeks of app-based support is being tested to see if it reduces depressive symptoms in postpartum women compared with a waitlist.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.